U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H28ClN3O4
Molecular Weight 397.896
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ABT-224

SMILES

CCCCOC(=O)CN1CCC(CC1)NC(=O)C2=CC(Cl)=C(N)C=C2OC

InChI

InChIKey=AQMLPMSSCWTNNN-UHFFFAOYSA-N
InChI=1S/C19H28ClN3O4/c1-3-4-9-27-18(24)12-23-7-5-13(6-8-23)22-19(25)14-10-15(20)16(21)11-17(14)26-2/h10-11,13H,3-9,12,21H2,1-2H3,(H,22,25)

HIDE SMILES / InChI

Molecular Formula C19H28ClN3O4
Molecular Weight 397.896
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys.
2000 Apr 25
Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
2001 Jul
Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo.
2001 Jun
Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro.
2001 Jun
Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546.
2001 Nov
A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia.
2001 Oct
Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model.
2002 Apr 5
Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report.
2002 Aug-Oct
Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action.
2002 Dec
Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors elicits neuroprotection after trimethyltin exposure in hippocampus.
2002 Dec 1
Positive modulators of AMPA receptors as a potential treatment for schizophrenia.
2002 Jul
Survival signaling and selective neuroprotection through glutamatergic transmission.
2002 Mar
Cortex Pharmaceuticals, Inc. Maintaining brain function goes a long way.
2003 Nov
Modulation of AMPA receptor kinetics differentially influences synaptic plasticity in the hippocampus.
2004
Amphetamine-evoked gene expression in striatopallidal neurons: regulation by corticostriatal afferents and the ERK/MAPK signaling cascade.
2004 Oct
Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.
2005 Apr
Positive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators have different impact on synaptic transmission in the thalamus and hippocampus.
2005 Apr
Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis.
2005 Jan 1
Positive modulation of glutamatergic receptors potentiates the suppressive effects of antipsychotics on conditioned avoidance responding in rats.
2006 Jun
Glutamate receptor-mediated restoration of experience-dependent place field expansion plasticity in aged rats.
2008 Jun
Ampakine CX516 ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulation.
2008 Nov
Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.
2009 Nov
Systematic review of pharmacological treatments in fragile X syndrome.
2009 Oct 13
Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses sub-chronic PCP-induced deficits in the novel object recognition task in rats.
2010 Feb 11
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 11:14:58 GMT 2023
Edited
by admin
on Sat Dec 16 11:14:58 GMT 2023
Record UNII
XVR3JT7PGA
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ABT-224
Code English
4-(4-AMINO-5-CHLORO-2-METHOXYBENZAMIDO)PIPERIDINE-1-ACETIC ACID BUTYL ESTER
Systematic Name English
BUTYL 2-(4-((4-AMINO-5-CHLORO-2-METHOXY-BENZOYL)AMINO)-1-PIPERIDYL)ACETATE
Systematic Name English
ABT224
Code English
1-PIPERIDINEACETIC ACID, 4-((4-AMINO-5-CHLORO-2-METHOXYBENZOYL)AMINO)-, BUTYL ESTER
Systematic Name English
AU-224
Code English
Code System Code Type Description
CAS
287399-47-7
Created by admin on Sat Dec 16 11:14:58 GMT 2023 , Edited by admin on Sat Dec 16 11:14:58 GMT 2023
PRIMARY
FDA UNII
XVR3JT7PGA
Created by admin on Sat Dec 16 11:14:58 GMT 2023 , Edited by admin on Sat Dec 16 11:14:58 GMT 2023
PRIMARY
PUBCHEM
9822171
Created by admin on Sat Dec 16 11:14:58 GMT 2023 , Edited by admin on Sat Dec 16 11:14:58 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY